Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Radiation Treatment for Age-Related Macular Degeneration SEMINARS IN OPHTHALMOLOGY Silva, R. A., Moshfeghi, A. A., Kaiser, P. K., Singh, R. P., Moshfeghi, D. M. 2011; 26 (3): 121-130

Abstract

Age-related macular degeneration (AMD) remains a devastating cause of visual loss among elderly individuals. While considerable progress has been made towards combating the disease, most recently with intravitreal anti-VEGF agents, visual outcomes are still limited by continued retinal pigment epithelium (RPE) degeneration and subsequent neurosensory retinal atrophy. Among the promising new treatment options being explored, radiotherapy appears apt to address the multifactorial etiology of AMD. Current investigative studies underway will hopefully yield clinical efficacy to complement this theoretical suitability for arresting visual loss.

View details for DOI 10.3109/08820538.2011.554486

View details for PubMedID 21609224